Widespread fraud in the generic drug industry
peterattiamd.com
peterattiamd.com
That makes a lot of sense to me, it seems to be a smart strategic move to have drug production under your control. Just like it's smart to be self-sufficient in the production of food.
They're pretty good, compared to random trash from India or China. They cannot match the volume, not even close, to be more than regional EU players.
https://www.nytimes.com/2019/05/13/books/review/bottle-of-li...
The book itself is written in this same tedious style (first 56 pages available as a preview):
https://books.google.com/books/about/Bottle_of_Lies.html?id=...
Zooming out a bit, it looks like a specific example of a wider trend of supply chains that are long and efficient until their fragility becomes clear thanks to a well-timed and well-placed break.
I wonder what other specific products have a dysfunctional market like this?
[1] https://www.economist.com/international/2019/09/14/a-dire-sc...
No, their target market is people who have no other choice. This is what regulatory capture gets you.
You have a white-label producer, and many store-brands that simply slap a label on that white-label product.
Obviously if the goal is to sell a product that's cheaper than the name-brand (Kellog's in this case), it's clear that's a race-to-the-bottom in terms of quality
Don't they patent that, too? Isn't that what the parent commentor is referring to when saying "it's been 123 years since Cornflakes were patented"—that the original manufacturer's exact factory design should be in the public domain by now?
The generics must cut corners (not grinding as fine? not baking as long?) that surely reduce costs by only a few pennies per box, but at the cost of greatly reduced sales overall. Maybe it has something to do with everyone knowing that the generics are bad as a class, so there's no point in any particular white-label manufacturer achieving any quality better than the bare minimum? Maybe there's a little-known breakfast cereal commodity market?
Years later after an investigation a decent chunk of generics actually went off the market because they were crap. This is a field that has faced unreasonably low levels of scrutiny historically. So it's no shock to see stories like this.